Clinical and Biological Features of Eligible Patients at Diagnosis
| Sex | |
| M | 138 (54.5%) |
| F | 115 (45.5%) |
| Age median | 37.8 |
| (range) | 2.2-73.9 |
| FAB M3 | 221 (86.4%) |
| M3v | 32 (12.6%) |
| WBC × 109/L median | 2.5 |
| (range) | 0.2-140.0 |
| Type of PML/RARα transcript | |
| Long (bcr 1-2) | 152 (61.5%) |
| Short (bcr 3) | 95 (38.5%) |
| NA | 6* |
| Sex | |
| M | 138 (54.5%) |
| F | 115 (45.5%) |
| Age median | 37.8 |
| (range) | 2.2-73.9 |
| FAB M3 | 221 (86.4%) |
| M3v | 32 (12.6%) |
| WBC × 109/L median | 2.5 |
| (range) | 0.2-140.0 |
| Type of PML/RARα transcript | |
| Long (bcr 1-2) | 152 (61.5%) |
| Short (bcr 3) | 95 (38.5%) |
| NA | 6* |
Abbreviation: NA, not available.
All had the t(15; 17).